136 related articles for article (PubMed ID: 18821686)
21. Systemic alterations in metal metabolism during inflammation as part of an integrated response to inflammation.
Powanda MC
Agents Actions Suppl; 1981; 8():121-35. PubMed ID: 7008550
[No Abstract] [Full Text] [Related]
22. Cytokines in rheumatoid arthritis.
Koch AE; Kunkel SL; Strieter RM
J Investig Med; 1995 Feb; 43(1):28-38. PubMed ID: 7719757
[No Abstract] [Full Text] [Related]
23. Inflammatory cytokines and hypoxia contribute to 18F-FDG uptake by cells involved in pannus formation in rheumatoid arthritis.
Matsui T; Nakata N; Nagai S; Nakatani A; Takahashi M; Momose T; Ohtomo K; Koyasu S
J Nucl Med; 2009 Jun; 50(6):920-6. PubMed ID: 19443596
[TBL] [Abstract][Full Text] [Related]
24. Do non-steroidal anti-inflammatory drugs influence chronic inflammation? The effects of piroxicam on chronic antigen-induced arthritis in rats.
Sigurdardottir SL; Freysdottir J; Vikingsdottir T; Valdimarsson H; Vikingsson A
Scand J Rheumatol; 2008; 37(6):469-76. PubMed ID: 19005999
[TBL] [Abstract][Full Text] [Related]
25. Cellular mechanisms and the role of cytokines in bone erosions in rheumatoid arthritis.
Gravallese EM; Goldring SR
Arthritis Rheum; 2000 Oct; 43(10):2143-51. PubMed ID: 11037873
[No Abstract] [Full Text] [Related]
26. Scopolin isolated from Erycibe obtusifolia Benth stems suppresses adjuvant-induced rat arthritis by inhibiting inflammation and angiogenesis.
Pan R; Dai Y; Gao X; Xia Y
Int Immunopharmacol; 2009 Jul; 9(7-8):859-69. PubMed ID: 19327410
[TBL] [Abstract][Full Text] [Related]
27. Rheumatoid arthritis and the emergence of immuno-autonomics.
Taylor PC; Holman AJ
Rheumatology (Oxford); 2019 Dec; 58(12):2079-2080. PubMed ID: 31177267
[No Abstract] [Full Text] [Related]
28. The cytokine network in rheumatoid arthritis.
Wilder RL; Remmers EF; Sano H; Case JP; Lafyatis R
Br J Rheumatol; 1991; 30 Suppl 2():44-7. PubMed ID: 1993258
[No Abstract] [Full Text] [Related]
29. Stress primes microglia to the presence of systemic inflammation: implications for environmental influences on the brain.
Perry VH
Brain Behav Immun; 2007 Jan; 21(1):45-6. PubMed ID: 17011745
[No Abstract] [Full Text] [Related]
30. Neural-immune interactions in health and disease.
Sternberg EM
J Clin Invest; 1997 Dec; 100(11):2641-7. PubMed ID: 9389725
[No Abstract] [Full Text] [Related]
31. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells.
González MA; Gonzalez-Rey E; Rico L; Büscher D; Delgado M
Arthritis Rheum; 2009 Apr; 60(4):1006-19. PubMed ID: 19333946
[TBL] [Abstract][Full Text] [Related]
32. Construction and characterization of a novel DNA vaccine that is potent antigen-specific tolerizing therapy for experimental arthritis by increasing CD4+CD25+Treg cells and inducing Th1 to Th2 shift in both cells and cytokines.
Song X; Liang F; Liu N; Luo Y; Xue H; Yuan F; Tan L; Sun Y; Xi C; Xi Y
Vaccine; 2009 Jan; 27(5):690-700. PubMed ID: 19095031
[TBL] [Abstract][Full Text] [Related]
33. Pathophysiology of rheumatoid arthritis: split or lump?
Boers M
Arthritis Rheum; 2008 Oct; 58(10):2925-7. PubMed ID: 18821696
[No Abstract] [Full Text] [Related]
34. Periodic, partial inhibition of IkappaB Kinase beta-mediated signaling yields therapeutic benefit in preclinical models of rheumatoid arthritis.
Gillooly KM; Pattoli MA; Taylor TL; Chen L; Cheng L; Gregor KR; Whitney GS; Susulic V; Watterson SH; Kempson J; Pitts WJ; Booth-Lute H; Yang G; Davies P; Kukral DW; Strnad J; McIntyre KW; Darienzo CJ; Salter-Cid L; Yang Z; Wang-Iverson DB; Burke JR
J Pharmacol Exp Ther; 2009 Nov; 331(2):349-60. PubMed ID: 19652024
[TBL] [Abstract][Full Text] [Related]
35. [The vicious circle that leads to rheumatoid arthritis; experimental evidence of the steps involved in this circle].
van Venrooij WJ; Pruijn GJ
Ned Tijdschr Geneeskd; 2009; 153():B232. PubMed ID: 19785789
[TBL] [Abstract][Full Text] [Related]
36. [Recent topics in histopathology associated with joint destruction in rheumatoid arthritis].
Sawai T; Uzuki M
Clin Calcium; 2009 Mar; 19(3):325-38. PubMed ID: 19252242
[TBL] [Abstract][Full Text] [Related]
37. Study guide inflammatory disorders. I. Classification, anatomy, and pathophysiology.
Snader TC
Am J Pharm Sci Support Public Health; 1974; 146(4):113-25. PubMed ID: 4425419
[No Abstract] [Full Text] [Related]
38. Differences in the injury/sprouting response of splenic noradrenergic nerves in Lewis rats with adjuvant-induced arthritis compared with rats treated with 6-hydroxydopamine.
Lorton D; Lubahn C; Sweeney S; Major A; Lindquist CA; Schaller J; Washington C; Bellinger DL
Brain Behav Immun; 2009 Feb; 23(2):276-85. PubMed ID: 18984038
[TBL] [Abstract][Full Text] [Related]
39. Controlling immunopathology at the expense of critical immune functions--a tipping of the balance by neuroendocrine-immune interactions.
Bonneau RH
Brain Behav Immun; 2007 Oct; 21(7):888-9. PubMed ID: 17656067
[No Abstract] [Full Text] [Related]
40. Alpha9 integrin and its ligands constitute critical joint microenvironments for development of autoimmune arthritis.
Kanayama M; Kurotaki D; Morimoto J; Asano T; Matsui Y; Nakayama Y; Saito Y; Ito K; Kimura C; Iwasaki N; Suzuki K; Harada T; Li HM; Uehara J; Miyazaki T; Minami A; Kon S; Uede T
J Immunol; 2009 Jun; 182(12):8015-25. PubMed ID: 19494327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
